Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
What is Qualigen Therapeutics's quote symbol?
What is the 52 week high and low for Qualigen Therapeutics (NASDAQ: QLGN)?
How much is Qualigen Therapeutics stock worth today?
How much is Qualigen Therapeutics's stock price per share?
What is Qualigen Therapeutics's Market Cap?